SEER(Seer, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $6.62M | $15.49M | $16.66M | $14.17M | $16.58M |
| 毛利润 | $3.41M | $7.09M | $8.51M | $7.05M | $8.46M |
| 营业利润 | −$71.47M | −$97.23M | −$103.46M | −$100.10M | −$77.99M |
| 净利润 | −$71.17M | −$92.97M | −$86.28M | −$86.60M | −$73.60M |
| 经营现金流 | −$46.35M | −$60.78M | −$59.06M | −$46.11M | −$44.45M |
| 自由现金流 | −$53.27M | −$71.05M | −$66.37M | −$49.69M | −$46.24M |
| 摊薄每股收益 | $-1.17 | $-1.49 | $-1.35 | — | — |